Syndromic surveillance of vaccine-associated adverse events in U.S. emergency departments

Vaccine. 2021 Jul 13;39(31):4250-4255. doi: 10.1016/j.vaccine.2021.06.030. Epub 2021 Jun 22.

Abstract

The Centers for Disease Control and Prevention explored use of emergency department (ED) visit data, during 2018-2020, from the National Syndromic Surveillance Program to monitor vaccine-associated adverse events (VAE) among all age groups. A combination of chief complaint terms and administrative diagnosis codes were used to detect VAE-related ED visits. Postvaccination fever was among the top 10 most frequently noted diagnoses. VAE annual trends demonstrated seasonality; visits trended upward starting in September of each year, coinciding with the administration of seasonal influenza vaccines. The 2020 VAE-related visit trend declined below the 2018 and 2019 baselines during March 22-September 5, 2020, before returning to the seasonal pattern. VAE-related visits declined in children aged 3-18 years in 2020 compared with 2018-2019, especially in the back-to-school months. These findings demonstrate that syndromic surveillance can complement traditional VAE reporting systems without an additional demand on data collection resources.

Keywords: Emergency department; Emergency medicine; Immunisation safety; Public health; Surveillance; Vaccine adverse events.

MeSH terms

  • Child
  • Data Collection
  • Emergency Service, Hospital
  • Humans
  • Influenza Vaccines* / adverse effects
  • Population Surveillance
  • Sentinel Surveillance*
  • United States / epidemiology

Substances

  • Influenza Vaccines